Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.051 0.1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.1
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.053 0.1
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.041 0.1
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.075 0.1
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.051 0.1
mRNA Erlotinib gCSI pan-cancer AAC 0.087 0.1
mRNA NSC 74859 CTRPv2 pan-cancer AAC 0.065 0.1
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.08 0.1
Download CSV